10x Genomics Inc (TXG)
14.14
-0.78
(-5.26%)
USD |
NASDAQ |
Nov 14, 16:00
14.11
-0.02
(-0.18%)
After-Hours: 20:00
10x Genomics Gross Profit Margin (Quarterly): 70.16% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 70.16% |
| June 30, 2024 | 68.07% |
| March 31, 2024 | 65.89% |
| December 31, 2023 | 62.93% |
| September 30, 2023 | 62.18% |
| June 30, 2023 | 67.85% |
| March 31, 2023 | 73.27% |
| December 31, 2022 | 76.43% |
| September 30, 2022 | 76.82% |
| June 30, 2022 | 75.83% |
| March 31, 2022 | 77.75% |
| December 31, 2021 | 80.77% |
| September 30, 2021 | 80.43% |
| Date | Value |
|---|---|
| June 30, 2021 | 95.76% |
| March 31, 2021 | 83.88% |
| December 31, 2020 | 83.16% |
| September 30, 2020 | 79.93% |
| June 30, 2020 | 76.57% |
| March 31, 2020 | 78.99% |
| December 31, 2019 | 77.98% |
| September 30, 2019 | 74.71% |
| June 30, 2019 | 73.12% |
| March 31, 2019 | 73.94% |
| December 31, 2018 | 70.53% |
| September 30, 2018 | 85.68% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
62.18%
Minimum
Sep 2023
95.76%
Maximum
Jun 2021
75.73%
Average
76.70%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Omnicell Inc | 43.29% |
| American Shared Hospital Services | 34.98% |
| Astrana Health Inc | 15.35% |
| Cryo-Cell International Inc | 73.65% |
| P3 Health Partners Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.99% |
| Return on Assets | -19.40% |
| Return on Invested Capital | -24.99% |
| Profit Margin (Quarterly) | -23.58% |
| Operating Margin (Quarterly) | -27.36% |
| Return on Net Operating Assets | -33.95% |